SERMs The benefits of estrogen without the risks?

被引：2

作者：

Cole, RC ^{[1
]}

Flaws, JA ^{[1
]}

Bush, TL ^{[1
]}

机构：

[1] Univ Maryland, Sch Med, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA

来源：

JOURNAL OF WOMENS HEALTH | 1998年 / 7卷 / 10期

关键词：

D O I：

10.1089/jwh.1998.7.1187

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

页码：1187 / 1189

页数：3

共 15 条

[1] Lack of effect of raloxifene on coronary artery atherosclerosis of postmenopausal monkeys [J].

Clarkson, TB ;

Anthony, MS ;

Jerome, CP .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (03) :721-726

[2] Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women [J].

Delmas, PD ;

Bjarnason, NH ;

Mitlak, BH ;

Ravoux, AC ;

Shah, AS ;

Huster, WJ ;

Draper, M ;

Christiansen, C .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (23) :1641-1647

[3] Reduced mortality associated with long-term postmenopausal estrogen therapy [J].

Ettinger, B ;

Friedman, GD ;

Bush, T ;

Quesenberry, CP .

OBSTETRICS AND GYNECOLOGY, 1996, 87 (01) :6-12

[4] Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study [J].

Fisher, B ;

Costantino, JP ;

Wickerham, DL ;

Redmond, CK ;

Kavanah, M ;

Cronin, WM ;

Vogel, V ;

Robidoux, A ;

Dimitrov, N ;

Atkins, J ;

Daly, M ;

Wieand, S ;

Tan-Chiu, E ;

Ford, L ;

Wolmark, N .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (18) :1371-1388

[5] Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors [J].

Fisher, B ;

Dignam, J ;

Bryant, J ;

DeCillis, A ;

Wickerham, DL ;

Wolmark, N ;

Costantino, J ;

Redmond, C ;

Fisher, ER ;

Bowman, DM ;

Deschenes, L ;

Dimitrov, NV ;

Margolese, RG ;

Robidoux, A ;

Shibata, H ;

Terz, J ;

Paterson, AHG ;

Feldman, MI ;

Farrar, W ;

Evans, J ;

Lickley, HL .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (21) :1529-1542

[6]

*FOOD DRUG ADM, 1997, END MET DRUGS ADV CO

[7]

FREI R, 1997, MED TRIBUNE OBSTET G, V4, P9

[8] Postmenopausal hormone therapy and mortality [J].

Grodstein, F ;

Stampfer, MJ ;

Colditz, GA ;

Willett, WC ;

Manson, JE ;

Joffe, M ;

Rosner, B ;

Fuchs, C ;

Hankinson, SE ;

Hunter, DJ ;

Hennekens, CH ;

Speizer, FE .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (25) :1769-1775

[9] Selective estrogen receptor modulators and postmenopausal women's health [J].

Hol, T ;

Cox, MB ;

Bryant, HU ;

Draper, MW .

JOURNAL OF WOMENS HEALTH, 1997, 6 (05) :523-531

[10] Femoral fractures in postmenopausal breast cancer patients treated with adjuvant tamoxifen [J].

Kristensen, B ;

Ejlertsen, B ;

Mouridsen, HT ;

Andersen, KW ;

Lauritzen, JB .

BREAST CANCER RESEARCH AND TREATMENT, 1996, 39 (03) :321-326

← 1 2 →